1 |
LU1540961759 |
HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund A Cap USD |
-3,44 % |
+18,79 % |
-0,30 |
2 |
LU2026682919 |
Candriam Equities L Biotechnology, V2 - Capitalisation |
-4,07 % |
+20,43 % |
-0,31 |
3 |
LU1540962054 |
HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund P Cap USD |
-3,94 % |
+19,62 % |
-0,32 |
4 |
LU0942225912 |
Candriam Equities L Biotechnology, R - Capitalisation |
-4,29 % |
+20,41 % |
-0,32 |
5 |
LU0317020203 |
Candriam Equities L Biotechnology, V - Capitalisation |
-4,30 % |
+20,27 % |
-0,32 |
|
27 |
LU2304361343 |
Janus Henderson Horizon Biotechnology Fund X2 USD |
-11,09 % |
+28,00 % |
-0,48 |
|
79 |
LU0767968745 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I GBP - Accumulating |
-10,57 % |
+11,98 % |
-1,07 |
80 |
DE000A3DCA95 |
BIT Biotech Opportunities S |
-35,23 % |
+30,99 % |
-1,21 |
81 |
DE000A3DCBA0 |
BIT Biotech Opportunities I-II |
-35,36 % |
+30,97 % |
-1,21 |
82 |
LU0415392835 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I CHF - Accumulating |
-14,91 % |
+13,79 % |
-1,24 |
83 |
LU0415392595 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions B CHF - Accumulating |
-15,51 % |
+13,79 % |
-1,29 |